Industry Research Reports
Home > Reports > Medical Devices & Consumables > Global Micro Invasive Glaucoma Surgery (MIGS) Devices Market Outlook, In‑Depth Analysis & Forecast to 2031
Global Micro Invasive Glaucoma Surgery (MIGS) Devices Market Outlook, In‑Depth Analysis & Forecast to 2031
Industry: Medical Devices & Consumables
Published Date: 2025-10-25
Pages: 141 Pages
Report ld: 5183880
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Micro Invasive Glaucoma Surgery (MIGS) Devices Market Size(US$)
CAGR 2025-2031
11.3%
Market Size,2031
USD 3,271
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 1,721 million
Market Forecast in 2031(Value)
US$ 3,271 million
CAGR
11.3%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Micro Invasive Glaucoma Surgery (MIGS) Devices market is projected to grow from US$ 1567 million in 2024 to US$ 3271 million by 2031, at a CAGR of 11.3% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Glaucoma is a disease characterized by optic disc atrophy and depression, visual field loss, and decreased vision. Impaired aqueous humor circulation in the eye causes elevated intraocular pressure (IOP), exceeding the optic nerve's tolerance, leading to chronic optic nerve damage. With the aging population, the number of glaucoma patients is increasing annually.
MIGS is a new surgical method that uses extremely small devices and very delicate operations to reduce intraocular pressure. Although traditional surgery can effectively reduce intraocular pressure, it brings more trauma and more postoperative complications. The difference is that MIGs can effectively reduce intraocular pressure and avoid complications, and can also be applied to patients whose glaucoma symptoms have not reached the advanced stage.Therefore, it has attracted considerable attention in the glaucoma treatment field and holds promising clinical application prospects. It has become a popular market segment for many ophthalmic medical device companies.
The market for minimally invasive glaucoma surgery (MIGS) devices is experiencing rapid growth. This growth is primarily driven by the clinical needs of 80 million glaucoma patients worldwide, an aging population, and increased healthcare coverage. Currently, the market is dominated by trabecular meshwork drainage devices (such as the iStent), accounting for 38% of the market share, but subconjunctival drainage (XEN Gel Stent) and suprachoroidal drainage (Hydrus) technologies are rapidly gaining market share. North America holds nearly 60% of the global market, followed closely by Europe. The Asia-Pacific region (particularly China) holds significant potential due to localized production and expanding healthcare coverage. In the competitive landscape, leading companies such as Glaukos, Alcon, and AbbVie are consolidating their advantages through technological innovations (such as AI-guided navigation and biodegradable stents), while emerging companies are focusing on differentiated indications and cost optimization. Future trends include expanding indications for early intervention, combination use with cataract surgery (expected to account for over 70% of the market share), and accelerated localized production in emerging markets.
Report Includes:
This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global Micro Invasive Glaucoma Surgery (MIGS) Devices market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region's dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- Glaukos Corporation
- Alcon
- AbbVie
- iSTAR Medical
- New World Medical
- Nova Eye Medical
- Sight Sciences
- HealthGuard Biomed
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- MIGS Stents
- MIGS Shunts
- Others
Segment by Application
- Hospital
- Ophthalmology Clinics
- Others
CHAPTER OUTLINE
Chapter 1: Defines the Micro Invasive Glaucoma Surgery (MIGS) Devices study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; top manufactures 2024 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Micro Invasive Glaucoma Surgery (MIGS) Devices: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Micro Invasive Glaucoma Surgery (MIGS) Devices Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 MIGS Stents
1.2.3 MIGS Shunts
1.2.4 Others
1.3 Market Segmentation by Application
1.3.1 Global Micro Invasive Glaucoma Surgery (MIGS) Devices Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Ophthalmology Clinics
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Micro Invasive Glaucoma Surgery (MIGS) Devices Revenue Estimates and Forecasts 2020-2031
2.2 Global Micro Invasive Glaucoma Surgery (MIGS) Devices Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Estimates and Forecasts 2020-2031
2.4 Global Micro Invasive Glaucoma Surgery (MIGS) Devices Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Micro Invasive Glaucoma Surgery (MIGS) Devices Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Micro Invasive Glaucoma Surgery (MIGS) Devices Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 MIGS Stents Market Size by Manufacturers
3.5.2 MIGS Shunts Market Size by Manufacturers
3.5.3 Others Market Size by Manufacturers
3.6 Global Micro Invasive Glaucoma Surgery (MIGS) Devices Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Micro Invasive Glaucoma Surgery (MIGS) Devices Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Micro Invasive Glaucoma Surgery (MIGS) Devices Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Micro Invasive Glaucoma Surgery (MIGS) Devices Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Micro Invasive Glaucoma Surgery (MIGS) Devices Sales and Revenue by Type (2020-2031)
6.4 North America Micro Invasive Glaucoma Surgery (MIGS) Devices Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Micro Invasive Glaucoma Surgery (MIGS) Devices Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Micro Invasive Glaucoma Surgery (MIGS) Devices Sales and Revenue by Type (2020-2031)
7.4 Europe Micro Invasive Glaucoma Surgery (MIGS) Devices Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Micro Invasive Glaucoma Surgery (MIGS) Devices Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Micro Invasive Glaucoma Surgery (MIGS) Devices Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Micro Invasive Glaucoma Surgery (MIGS) Devices Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Micro Invasive Glaucoma Surgery (MIGS) Devices Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Micro Invasive Glaucoma Surgery (MIGS) Devices Sales and Revenue by Type (2020-2031)
9.4 Central and South America Micro Invasive Glaucoma Surgery (MIGS) Devices Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Micro Invasive Glaucoma Surgery (MIGS) Devices Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Micro Invasive Glaucoma Surgery (MIGS) Devices Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Micro Invasive Glaucoma Surgery (MIGS) Devices Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Micro Invasive Glaucoma Surgery (MIGS) Devices Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Glaukos Corporation
11.1.1 Glaukos Corporation Corporation Information
11.1.2 Glaukos Corporation Business Overview
11.1.3 Glaukos Corporation Micro Invasive Glaucoma Surgery (MIGS) Devices Product Models, Descriptions and Specifications
11.1.4 Glaukos Corporation Micro Invasive Glaucoma Surgery (MIGS) Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Glaukos Corporation Micro Invasive Glaucoma Surgery (MIGS) Devices Sales by Product in 2024
11.1.6 Glaukos Corporation Micro Invasive Glaucoma Surgery (MIGS) Devices Sales by Application in 2024
11.1.7 Glaukos Corporation Micro Invasive Glaucoma Surgery (MIGS) Devices Sales by Geographic Area in 2024
11.1.8 Glaukos Corporation Micro Invasive Glaucoma Surgery (MIGS) Devices SWOT Analysis
11.1.9 Glaukos Corporation Recent Developments
11.2 Alcon
11.2.1 Alcon Corporation Information
11.2.2 Alcon Business Overview
11.2.3 Alcon Micro Invasive Glaucoma Surgery (MIGS) Devices Product Models, Descriptions and Specifications
11.2.4 Alcon Micro Invasive Glaucoma Surgery (MIGS) Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Alcon Micro Invasive Glaucoma Surgery (MIGS) Devices Sales by Product in 2024
11.2.6 Alcon Micro Invasive Glaucoma Surgery (MIGS) Devices Sales by Application in 2024
11.2.7 Alcon Micro Invasive Glaucoma Surgery (MIGS) Devices Sales by Geographic Area in 2024
11.2.8 Alcon Micro Invasive Glaucoma Surgery (MIGS) Devices SWOT Analysis
11.2.9 Alcon Recent Developments
11.3 AbbVie
11.3.1 AbbVie Corporation Information
11.3.2 AbbVie Business Overview
11.3.3 AbbVie Micro Invasive Glaucoma Surgery (MIGS) Devices Product Models, Descriptions and Specifications
11.3.4 AbbVie Micro Invasive Glaucoma Surgery (MIGS) Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 AbbVie Micro Invasive Glaucoma Surgery (MIGS) Devices Sales by Product in 2024
11.3.6 AbbVie Micro Invasive Glaucoma Surgery (MIGS) Devices Sales by Application in 2024
11.3.7 AbbVie Micro Invasive Glaucoma Surgery (MIGS) Devices Sales by Geographic Area in 2024
11.3.8 AbbVie Micro Invasive Glaucoma Surgery (MIGS) Devices SWOT Analysis
11.3.9 AbbVie Recent Developments
11.4 iSTAR Medical
11.4.1 iSTAR Medical Corporation Information
11.4.2 iSTAR Medical Business Overview
11.4.3 iSTAR Medical Micro Invasive Glaucoma Surgery (MIGS) Devices Product Models, Descriptions and Specifications
11.4.4 iSTAR Medical Micro Invasive Glaucoma Surgery (MIGS) Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 iSTAR Medical Micro Invasive Glaucoma Surgery (MIGS) Devices Sales by Product in 2024
11.4.6 iSTAR Medical Micro Invasive Glaucoma Surgery (MIGS) Devices Sales by Application in 2024
11.4.7 iSTAR Medical Micro Invasive Glaucoma Surgery (MIGS) Devices Sales by Geographic Area in 2024
11.4.8 iSTAR Medical Micro Invasive Glaucoma Surgery (MIGS) Devices SWOT Analysis
11.4.9 iSTAR Medical Recent Developments
11.5 New World Medical
11.5.1 New World Medical Corporation Information
11.5.2 New World Medical Business Overview
11.5.3 New World Medical Micro Invasive Glaucoma Surgery (MIGS) Devices Product Models, Descriptions and Specifications
11.5.4 New World Medical Micro Invasive Glaucoma Surgery (MIGS) Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 New World Medical Micro Invasive Glaucoma Surgery (MIGS) Devices Sales by Product in 2024
11.5.6 New World Medical Micro Invasive Glaucoma Surgery (MIGS) Devices Sales by Application in 2024
11.5.7 New World Medical Micro Invasive Glaucoma Surgery (MIGS) Devices Sales by Geographic Area in 2024
11.5.8 New World Medical Micro Invasive Glaucoma Surgery (MIGS) Devices SWOT Analysis
11.5.9 New World Medical Recent Developments
11.6 Nova Eye Medical
11.6.1 Nova Eye Medical Corporation Information
11.6.2 Nova Eye Medical Business Overview
11.6.3 Nova Eye Medical Micro Invasive Glaucoma Surgery (MIGS) Devices Product Models, Descriptions and Specifications
11.6.4 Nova Eye Medical Micro Invasive Glaucoma Surgery (MIGS) Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Nova Eye Medical Recent Developments
11.7 Sight Sciences
11.7.1 Sight Sciences Corporation Information
11.7.2 Sight Sciences Business Overview
11.7.3 Sight Sciences Micro Invasive Glaucoma Surgery (MIGS) Devices Product Models, Descriptions and Specifications
11.7.4 Sight Sciences Micro Invasive Glaucoma Surgery (MIGS) Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Sight Sciences Recent Developments
11.8 HealthGuard Biomed
11.8.1 HealthGuard Biomed Corporation Information
11.8.2 HealthGuard Biomed Business Overview
11.8.3 HealthGuard Biomed Micro Invasive Glaucoma Surgery (MIGS) Devices Product Models, Descriptions and Specifications
11.8.4 HealthGuard Biomed Micro Invasive Glaucoma Surgery (MIGS) Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 HealthGuard Biomed Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Micro Invasive Glaucoma Surgery (MIGS) Devices Industry Chain
12.2 Micro Invasive Glaucoma Surgery (MIGS) Devices Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Micro Invasive Glaucoma Surgery (MIGS) Devices Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Micro Invasive Glaucoma Surgery (MIGS) Devices Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Micro Invasive Glaucoma Surgery (MIGS) Devices Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global Micro Invasive Glaucoma Surgery (MIGS) Devices Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Micro Invasive Glaucoma Surgery (MIGS) Devices Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Micro Invasive Glaucoma Surgery (MIGS) Devices Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Micro Invasive Glaucoma Surgery (MIGS) Devices Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Micro Invasive Glaucoma Surgery (MIGS) Devices Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
Table 7. Global Micro Invasive Glaucoma Surgery (MIGS) Devices Sales by Region (2020-2025) & (K Units)
Table 8. Global Micro Invasive Glaucoma Surgery (MIGS) Devices Sales by Region (2026-2031) & (K Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Micro Invasive Glaucoma Surgery (MIGS) Devices Sales by Manufacturers (2020-2025) & (K Units)
Table 11. Global Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Share by Manufacturers (2020-2025)
Table 12. Global Micro Invasive Glaucoma Surgery (MIGS) Devices Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Micro Invasive Glaucoma Surgery (MIGS) Devices Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Micro Invasive Glaucoma Surgery (MIGS) Devices by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Micro Invasive Glaucoma Surgery (MIGS) Devices as of 2024)
Table 16. Global Micro Invasive Glaucoma Surgery (MIGS) Devices Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Micro Invasive Glaucoma Surgery (MIGS) Devices Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
Table 18. Key Manufacturers Micro Invasive Glaucoma Surgery (MIGS) Devices Manufacturing Base and Headquarters
Table 19. Global Micro Invasive Glaucoma Surgery (MIGS) Devices Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Micro Invasive Glaucoma Surgery (MIGS) Devices Sales by Type (2020-2025) & (K Units)
Table 23. Global Micro Invasive Glaucoma Surgery (MIGS) Devices Sales by Type (2026-2031) & (K Units)
Table 24. Global Micro Invasive Glaucoma Surgery (MIGS) Devices Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Micro Invasive Glaucoma Surgery (MIGS) Devices Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Micro Invasive Glaucoma Surgery (MIGS) Devices ASP by Type (2020-2031) & (US$/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Micro Invasive Glaucoma Surgery (MIGS) Devices Sales by Application (2020-2025) & (K Units)
Table 29. Global Micro Invasive Glaucoma Surgery (MIGS) Devices Sales by Application (2026-2031) & (K Units)
Table 30. Micro Invasive Glaucoma Surgery (MIGS) Devices High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Micro Invasive Glaucoma Surgery (MIGS) Devices Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Micro Invasive Glaucoma Surgery (MIGS) Devices Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Micro Invasive Glaucoma Surgery (MIGS) Devices ASP by Application (2020-2031) & (US$/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Micro Invasive Glaucoma Surgery (MIGS) Devices Growth Accelerators and Market Barriers
Table 37. North America Micro Invasive Glaucoma Surgery (MIGS) Devices Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Micro Invasive Glaucoma Surgery (MIGS) Devices Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Micro Invasive Glaucoma Surgery (MIGS) Devices Growth Accelerators and Market Barriers
Table 40. Europe Micro Invasive Glaucoma Surgery (MIGS) Devices Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Micro Invasive Glaucoma Surgery (MIGS) Devices Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Micro Invasive Glaucoma Surgery (MIGS) Devices Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Micro Invasive Glaucoma Surgery (MIGS) Devices Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Micro Invasive Glaucoma Surgery (MIGS) Devices Growth Accelerators and Market Barriers
Table 45. Southeast Asia Micro Invasive Glaucoma Surgery (MIGS) Devices Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Micro Invasive Glaucoma Surgery (MIGS) Devices Investment Opportunities and Key Challenges
Table 47. Central and South America Micro Invasive Glaucoma Surgery (MIGS) Devices Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Micro Invasive Glaucoma Surgery (MIGS) Devices Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Micro Invasive Glaucoma Surgery (MIGS) Devices Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. Glaukos Corporation Corporation Information
Table 51. Glaukos Corporation Description and Major Businesses
Table 52. Glaukos Corporation Product Models, Descriptions and Specifications
Table 53. Glaukos Corporation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 54. Glaukos Corporation Sales Value Proportion by Product in 2024
Table 55. Glaukos Corporation Sales Value Proportion by Application in 2024
Table 56. Glaukos Corporation Sales Value Proportion by Geographic Area in 2024
Table 57. Glaukos Corporation Micro Invasive Glaucoma Surgery (MIGS) Devices SWOT Analysis
Table 58. Glaukos Corporation Recent Developments
Table 59. Alcon Corporation Information
Table 60. Alcon Description and Major Businesses
Table 61. Alcon Product Models, Descriptions and Specifications
Table 62. Alcon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 63. Alcon Sales Value Proportion by Product in 2024
Table 64. Alcon Sales Value Proportion by Application in 2024
Table 65. Alcon Sales Value Proportion by Geographic Area in 2024
Table 66. Alcon Micro Invasive Glaucoma Surgery (MIGS) Devices SWOT Analysis
Table 67. Alcon Recent Developments
Table 68. AbbVie Corporation Information
Table 69. AbbVie Description and Major Businesses
Table 70. AbbVie Product Models, Descriptions and Specifications
Table 71. AbbVie Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. AbbVie Sales Value Proportion by Product in 2024
Table 73. AbbVie Sales Value Proportion by Application in 2024
Table 74. AbbVie Sales Value Proportion by Geographic Area in 2024
Table 75. AbbVie Micro Invasive Glaucoma Surgery (MIGS) Devices SWOT Analysis
Table 76. AbbVie Recent Developments
Table 77. iSTAR Medical Corporation Information
Table 78. iSTAR Medical Description and Major Businesses
Table 79. iSTAR Medical Product Models, Descriptions and Specifications
Table 80. iSTAR Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. iSTAR Medical Sales Value Proportion by Product in 2024
Table 82. iSTAR Medical Sales Value Proportion by Application in 2024
Table 83. iSTAR Medical Sales Value Proportion by Geographic Area in 2024
Table 84. iSTAR Medical Micro Invasive Glaucoma Surgery (MIGS) Devices SWOT Analysis
Table 85. iSTAR Medical Recent Developments
Table 86. New World Medical Corporation Information
Table 87. New World Medical Description and Major Businesses
Table 88. New World Medical Product Models, Descriptions and Specifications
Table 89. New World Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. New World Medical Sales Value Proportion by Product in 2024
Table 91. New World Medical Sales Value Proportion by Application in 2024
Table 92. New World Medical Sales Value Proportion by Geographic Area in 2024
Table 93. New World Medical Micro Invasive Glaucoma Surgery (MIGS) Devices SWOT Analysis
Table 94. New World Medical Recent Developments
Table 95. Nova Eye Medical Corporation Information
Table 96. Nova Eye Medical Description and Major Businesses
Table 97. Nova Eye Medical Product Models, Descriptions and Specifications
Table 98. Nova Eye Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 99. Nova Eye Medical Recent Developments
Table 100. Sight Sciences Corporation Information
Table 101. Sight Sciences Description and Major Businesses
Table 102. Sight Sciences Product Models, Descriptions and Specifications
Table 103. Sight Sciences Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 104. Sight Sciences Recent Developments
Table 105. HealthGuard Biomed Corporation Information
Table 106. HealthGuard Biomed Description and Major Businesses
Table 107. HealthGuard Biomed Product Models, Descriptions and Specifications
Table 108. HealthGuard Biomed Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 109. HealthGuard Biomed Recent Developments
Table 110. Key Raw Materials Distribution
Table 111. Raw Materials Key Suppliers
Table 112. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 113. Milestones in Production Technology Evolution
Table 114. Distributors List
Table 115. Market Trends and Market Evolution
Table 116. Market Drivers and Opportunities
Table 117. Market Challenges, Risks, and Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Micro Invasive Glaucoma Surgery (MIGS) Devices Product Picture
Figure 2. Global Micro Invasive Glaucoma Surgery (MIGS) Devices Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. MIGS Stents Product Picture
Figure 4. MIGS Shunts Product Picture
Figure 5. Others Product Picture
Figure 6. Global Micro Invasive Glaucoma Surgery (MIGS) Devices Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 7. Hospital
Figure 8. Ophthalmology Clinics
Figure 9. Others
Figure 10. Micro Invasive Glaucoma Surgery (MIGS) Devices Report Years Considered
Figure 11. Global Micro Invasive Glaucoma Surgery (MIGS) Devices Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Micro Invasive Glaucoma Surgery (MIGS) Devices Revenue (2020-2031) & (US$ Million)
Figure 13. Global Micro Invasive Glaucoma Surgery (MIGS) Devices Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 14. Global Micro Invasive Glaucoma Surgery (MIGS) Devices Revenue Market Share by Region (2020-2031)
Figure 15. Global Micro Invasive Glaucoma Surgery (MIGS) Devices Sales (2020-2031) & (K Units)
Figure 16. Global Micro Invasive Glaucoma Surgery (MIGS) Devices Sales (CAGR) by Region (2020-2031) (K Units)
Figure 17. Global Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Market Share by Region (2020-2031)
Figure 18. Top 5 and Top 10 Manufacturers Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Volume Market Share in 2024
Figure 19. Global Micro Invasive Glaucoma Surgery (MIGS) Devices Revenue Market Share Ranking (2024)
Figure 20. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 21. MIGS Stents Revenue Market Share by Manufacturer in 2024
Figure 22. MIGS Shunts Revenue Market Share by Manufacturer in 2024
Figure 23. Others Revenue Market Share by Manufacturer in 2024
Figure 24. Global Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Market Share by Type (2020-2031)
Figure 25. Global Micro Invasive Glaucoma Surgery (MIGS) Devices Revenue Market Share by Type (2020-2031)
Figure 26. Global Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Market Share by Application (2020-2031)
Figure 27. Global Micro Invasive Glaucoma Surgery (MIGS) Devices Revenue Market Share by Application (2020-2031)
Figure 28. North America Micro Invasive Glaucoma Surgery (MIGS) Devices Sales YoY (2020-2031) & (K Units)
Figure 29. North America Micro Invasive Glaucoma Surgery (MIGS) Devices Revenue YoY (2020-2031) & (US$ Million)
Figure 30. North America Top 5 Manufacturers Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Revenue (US$ Million) in 2024
Figure 31. North America Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Volume (K Units) by Type (2020- 2031)
Figure 32. North America Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 33. North America Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Volume (K Units) by Application (2020-2031)
Figure 34. North America Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Revenue (US$ Million) by Application (2020-2031)
Figure 35. US Micro Invasive Glaucoma Surgery (MIGS) Devices Revenue (2020-2031) & (US$ Million)
Figure 36. Canada Micro Invasive Glaucoma Surgery (MIGS) Devices Revenue (2020-2031) & (US$ Million)
Figure 37. Mexico Micro Invasive Glaucoma Surgery (MIGS) Devices Revenue (2020-2031) & (US$ Million)
Figure 38. Europe Micro Invasive Glaucoma Surgery (MIGS) Devices Sales YoY (2020-2031) & (K Units)
Figure 39. Europe Micro Invasive Glaucoma Surgery (MIGS) Devices Revenue YoY (2020-2031) & (US$ Million)
Figure 40. Europe Top 5 Manufacturers Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Revenue (US$ Million) in 2024
Figure 41. Europe Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Volume (K Units) by Type (2020-2031)
Figure 42. Europe Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Revenue (US$ Million) by Type (2020-2031)
Figure 43. Europe Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Volume (K Units) by Application (2020-2031)
Figure 44. Europe Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Revenue (US$ Million) by Application (2020-2031)
Figure 45. Germany Micro Invasive Glaucoma Surgery (MIGS) Devices Revenue (2020-2031) & (US$ Million)
Figure 46. France Micro Invasive Glaucoma Surgery (MIGS) Devices Revenue (2020-2031) & (US$ Million)
Figure 47. U.K. Micro Invasive Glaucoma Surgery (MIGS) Devices Revenue (2020-2031) & (US$ Million)
Figure 48. Italy Micro Invasive Glaucoma Surgery (MIGS) Devices Revenue (2020-2031) & (US$ Million)
Figure 49. Russia Micro Invasive Glaucoma Surgery (MIGS) Devices Revenue (2020-2031) & (US$ Million)
Figure 50. Asia-Pacific Micro Invasive Glaucoma Surgery (MIGS) Devices Sales YoY (2020-2031) & (K Units)
Figure 51. Asia-Pacific Micro Invasive Glaucoma Surgery (MIGS) Devices Revenue YoY (2020-2031) & (US$ Million)
Figure 52. Asia-Pacific Top 8 Manufacturers Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Revenue (US$ Million) in 2024
Figure 53. Asia-Pacific Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Volume (K Units) by Type (2020- 2031)
Figure 54. Asia-Pacific Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 55. Asia-Pacific Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Volume (K Units) by Application (2020-2031)
Figure 56. Asia-Pacific Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Revenue (US$ Million) by Application (2020-2031)
Figure 57. Indonesia Micro Invasive Glaucoma Surgery (MIGS) Devices Revenue (2020-2031) & (US$ Million)
Figure 58. Japan Micro Invasive Glaucoma Surgery (MIGS) Devices Revenue (2020-2031) & (US$ Million)
Figure 59. South Korea Micro Invasive Glaucoma Surgery (MIGS) Devices Revenue (2020-2031) & (US$ Million)
Figure 60. China Taiwan Micro Invasive Glaucoma Surgery (MIGS) Devices Revenue (2020-2031) & (US$ Million)
Figure 61. India Micro Invasive Glaucoma Surgery (MIGS) Devices Revenue (2020-2031) & (US$ Million)
Figure 62. Central and South America Micro Invasive Glaucoma Surgery (MIGS) Devices Sales YoY (2020-2031) & (K Units)
Figure 63. Central and South America Micro Invasive Glaucoma Surgery (MIGS) Devices Revenue YoY (2020-2031) & (US$ Million)
Figure 64. Central and South America Top 5 Manufacturers Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Revenue (US$ Million) in 2024
Figure 65. Central and South America Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Volume (K Units) by Type (2021-2031)
Figure 66. Central and South America Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Revenue (US$ Million) by Type (2020-2031)
Figure 67. Central and South America Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Volume (K Units) by Application (2020-2031)
Figure 68. Central and South America Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Revenue (US$ Million) by Application (2020-2031)
Figure 69. Brazil Micro Invasive Glaucoma Surgery (MIGS) Devices Revenue (2020-2025) & (US$ Million)
Figure 70. Argentina Micro Invasive Glaucoma Surgery (MIGS) Devices Revenue (2020-2025) & (US$ Million)
Figure 71. Middle East, and Africa Micro Invasive Glaucoma Surgery (MIGS) Devices Sales YoY (2020-2031) & (K Units)
Figure 72. Middle East and Africa Micro Invasive Glaucoma Surgery (MIGS) Devices Revenue YoY (2020-2031) & (US$ Million)
Figure 73. Middle East and Africa Top 5 Manufacturers Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Revenue (US$ Million) in 2024
Figure 74. Middle East and Africa Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Volume (K Units) by Type (2021-2031)
Figure 75. South America Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Revenue (US$ Million) by Type (2020-2031)
Figure 76. Middle East and Africa Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Volume (K Units) by Application (2020-2031)
Figure 77. Middle East and Africa Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Revenue (US$ Million) by Application (2020-2031)
Figure 78. GCC Countries Micro Invasive Glaucoma Surgery (MIGS) Devices Revenue (2020-2025) & (US$ Million)
Figure 79. Turkey Micro Invasive Glaucoma Surgery (MIGS) Devices Revenue (2020-2025) & (US$ Million)
Figure 80. Egypt Micro Invasive Glaucoma Surgery (MIGS) Devices Revenue (2020-2025) & (US$ Million)
Figure 81. South Africa Micro Invasive Glaucoma Surgery (MIGS) Devices Revenue (2020-2025) & (US$ Million)
Figure 82. Micro Invasive Glaucoma Surgery (MIGS) Devices Industry Chain Mapping
Figure 83. Regional Micro Invasive Glaucoma Surgery (MIGS) Devices Manufacturing Base Distribution (%)
Figure 84. Global Micro Invasive Glaucoma Surgery (MIGS) Devices Production Market Share by Region (2020-2031)
Figure 85. Micro Invasive Glaucoma Surgery (MIGS) Devices Production Process
Figure 86. Regional Micro Invasive Glaucoma Surgery (MIGS) Devices Production Cost Structure
Figure 87. Channels of Distribution (Direct Vs Distribution)
Figure 88. Bottom-up and Top-down Approaches for This Report
Figure 89. Data Triangulation
Figure 90. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What was the global market size of Micro Invasive Glaucoma Surgery (MIGS) Devices in 2031?
The global market size of Micro Invasive Glaucoma Surgery (MIGS) Devices in 2031 was 3271 Million USD.
Which region is expected to have the highest market share?
What was the global market size of Micro Invasive Glaucoma Surgery (MIGS) Devices in 2025?
What is the annual compound growth rate of the global Micro Invasive Glaucoma Surgery (MIGS) Devices market size from 2025 to 2031?
Which companies rank high in the global Micro Invasive Glaucoma Surgery (MIGS) Devices market?
Related Reports
Global Micro Invasive Glaucoma Surgery (MIGS) Devices Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Micro Invasive Glaucoma Surgery (MIGS) Devices market is projected to grow from US$ 1721 million in 2025 to US$ 3603 million by 2032, at a CAGR of 11.3% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-09
Pages: 137
USD 4900.00
(Single User License)
Global Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Micro Invasive Glaucoma Surgery (MIGS) Devices market size was US$ 1721 million in 2025 and is forecast to reach a readjusted size of US$ 3603 million by 2032 with a CAGR of 11.3% during the forecast period 2026-2032.
Published Date: 2026-03-09
Pages: 79
USD 4250.00
(Single User License)
Micro Invasive Glaucoma Surgery (MIGS) Devices- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Micro Invasive Glaucoma Surgery (MIGS) Devices was estimated to be worth US$ 1721 million in 2025 and is projected to reach US$ 3603 million, growing at a CAGR of 11.3% from 2026 to 2032.
Published Date: 2026-03-05
Pages: 108
USD 3950.00
(Single User License)
Global Micro Invasive Glaucoma Surgery (MIGS) Devices Market Research Report 2026
The global Micro Invasive Glaucoma Surgery (MIGS) Devices market was valued at US$ 1721 million in 2025 and is anticipated to reach US$ 3603 million by 2032, at a CAGR of 11.3% from 2026 to 2032.
Published Date: 2026-03-05
Pages: 111
USD 2900.00
(Single User License)
Micro Invasive Glaucoma Surgery (MIGS) Devices - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Micro Invasive Glaucoma Surgery (MIGS) Devices was estimated to be worth US$ 1567 million in 2024 and is forecast to a readjusted size of US$ 3271 million by 2031 with a CAGR of 11.3% during the forecast period 2025-2031.
Published Date: 2025-10-17
Pages: 92
USD 3950.00
(Single User License)
Global Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Micro Invasive Glaucoma Surgery (MIGS) Devices market size was US$ 1567 million in 2024 and is forecast to a readjusted size of US$ 3271 million by 2031 with a CAGR of 11.3% during the forecast period 2025-2031.
Published Date: 2025-10-17
Pages: 79
USD 4250.00
(Single User License)
Global Micro Invasive Glaucoma Surgery (MIGS) Devices Market Research Report 2025
The global market for Micro Invasive Glaucoma Surgery (MIGS) Devices was valued at US$ 1567 million in the year 2024 and is projected to reach a revised size of US$ 3271 million by 2031, growing at a CAGR of 11.3% during the forecast period.
Published Date: 2025-10-17
Pages: 85
USD 2900.00
(Single User License)
Micro Invasive Glaucoma Surgery (MIGS) Devices- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Micro Invasive Glaucoma Surgery (MIGS) Devices was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-21
Pages: 83
USD 3950.00
(Single User License)
Global and China Micro Invasive Glaucoma Surgery (MIGS) Devices Market Report & Forecast 2024-2030
MIGS is a new surgical method that uses extremely small devices and very delicate operations to reduce intraocular pressure. Although traditional surgery can effectively reduce intraocular pressure, it brings more trauma and more postoperative complications. The difference is that MIGs can effectively reduce intraocular pressure and avoid complications, and can also be applied to patients whose glaucoma symptoms have not reached the advanced stage.
Published Date: 2024-07-17
Pages: 94
USD 4350.00
(Single User License)
Micro Invasive Glaucoma Surgery (MIGS) Devices- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
MIGS is a new surgical method that uses extremely small devices and very delicate operations to reduce intraocular pressure. Although traditional surgery can effectively reduce intraocular pressure, it brings more trauma and more postoperative complications. The difference is that MIGs can effectively reduce intraocular pressure and avoid complications, and can also be applied to patients whose glaucoma symptoms have not reached the advanced stage.
Published Date: 2024-07-17
Pages: 80
USD 3950.00
(Single User License)
Global Micro Invasive Glaucoma Surgery (MIGS) Devices Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Micro Invasive Glaucoma Surgery (MIGS) Devices market is projected to grow from US$ 1721 million in 2025 to US$ 3603 million by 2032, at a CAGR of 11.3% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-09
Pages: 137
USD 4900.00 (Single User License)Global Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Micro Invasive Glaucoma Surgery (MIGS) Devices market size was US$ 1721 million in 2025 and is forecast to reach a readjusted size of US$ 3603 million by 2032 with a CAGR of 11.3% during the forecast period 2026-2032.
Published: 2026-03-09
Pages: 79
USD 4250.00 (Single User License)Micro Invasive Glaucoma Surgery (MIGS) Devices- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Micro Invasive Glaucoma Surgery (MIGS) Devices was estimated to be worth US$ 1721 million in 2025 and is projected to reach US$ 3603 million, growing at a CAGR of 11.3% from 2026 to 2032.
Published: 2026-03-05
Pages: 108
USD 3950.00 (Single User License)Global Micro Invasive Glaucoma Surgery (MIGS) Devices Market Research Report 2026
The global Micro Invasive Glaucoma Surgery (MIGS) Devices market was valued at US$ 1721 million in 2025 and is anticipated to reach US$ 3603 million by 2032, at a CAGR of 11.3% from 2026 to 2032.
Published: 2026-03-05
Pages: 111
USD 2900.00 (Single User License)Micro Invasive Glaucoma Surgery (MIGS) Devices - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Micro Invasive Glaucoma Surgery (MIGS) Devices was estimated to be worth US$ 1567 million in 2024 and is forecast to a readjusted size of US$ 3271 million by 2031 with a CAGR of 11.3% during the forecast period 2025-2031.
Published: 2025-10-17
Pages: 92
USD 3950.00 (Single User License)Global Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Micro Invasive Glaucoma Surgery (MIGS) Devices market size was US$ 1567 million in 2024 and is forecast to a readjusted size of US$ 3271 million by 2031 with a CAGR of 11.3% during the forecast period 2025-2031.
Published: 2025-10-17
Pages: 79
USD 4250.00 (Single User License)Global Micro Invasive Glaucoma Surgery (MIGS) Devices Market Research Report 2025
The global market for Micro Invasive Glaucoma Surgery (MIGS) Devices was valued at US$ 1567 million in the year 2024 and is projected to reach a revised size of US$ 3271 million by 2031, growing at a CAGR of 11.3% during the forecast period.
Published: 2025-10-17
Pages: 85
USD 2900.00 (Single User License)Micro Invasive Glaucoma Surgery (MIGS) Devices- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Micro Invasive Glaucoma Surgery (MIGS) Devices was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-21
Pages: 83
USD 3950.00 (Single User License)Global and China Micro Invasive Glaucoma Surgery (MIGS) Devices Market Report & Forecast 2024-2030
MIGS is a new surgical method that uses extremely small devices and very delicate operations to reduce intraocular pressure. Although traditional surgery can effectively reduce intraocular pressure, it brings more trauma and more postoperative complications. The difference is that MIGs can effectively reduce intraocular pressure and avoid complications, and can also be applied to patients whose glaucoma symptoms have not reached the advanced stage.
Published: 2024-07-17
Pages: 94
USD 4350.00 (Single User License)Micro Invasive Glaucoma Surgery (MIGS) Devices- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
MIGS is a new surgical method that uses extremely small devices and very delicate operations to reduce intraocular pressure. Although traditional surgery can effectively reduce intraocular pressure, it brings more trauma and more postoperative complications. The difference is that MIGs can effectively reduce intraocular pressure and avoid complications, and can also be applied to patients whose glaucoma symptoms have not reached the advanced stage.
Published: 2024-07-17
Pages: 80
USD 3950.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now